Search

Displaying results 5511 - 5520 of 10000 in total
  1. Drug

    Dichlorophen

    go.drugbank.com/drugs/DB11396
    InvestigationalVet approved

    Dichlorophen is an antimicrobial agent shown to exert activity against cestodes, protozoa, fungi, and bacteria.

  2. Drug

    Alinidine

    go.drugbank.com/drugs/DB20618
    Experimental

    Alinidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Alinidine is a a2 adrenoreceptor agonist. Alinidine has a monoisotopic molecular weight of 269.05 Da.

    Synonyms: St 567 br (as hbr)
  3. Drug

    Goxalapladib

    go.drugbank.com/drugs/DB20736
    Experimental

    Goxalapladib is a small molecule drug. The usage of the INN stem '-pladib' in the name indicates that Goxalapladib is a phospholipase A2​ inhibitor. … Goxalapladib has a monoisotopic molecular weight of 718.29 Da.

  4. Drug

    Indanidine

    go.drugbank.com/drugs/DB20950
    Experimental

    Indanidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Indanidine is a a2 adrenoreceptor agonist. … Indanidine has a monoisotopic molecular weight of 215.12 Da.

  5. Drug

    Nelipepimut-S

    go.drugbank.com/drugs/DB06226
    Investigational

  6. Drug

    NPI 32101

    go.drugbank.com/drugs/DB05264
    Experimental

    NPI 32101 possesses both anti-inflammatory and broad spectrum antimicrobial activities. This combination of pharmacological properties may have additional therapeutic uses beyond dermatology.

  7. Drug

    Rabeximod

    go.drugbank.com/drugs/DB05772
    Investigational

    Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.

  8. Drug

    SAR-125844

    go.drugbank.com/drugs/DB15382
    Investigational

    SAR-125844 is under investigation in clinical trial NCT01391533 (Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors).

  9. Drug

    Birtamimab

    go.drugbank.com/drugs/DB16414
    Investigational

    Birtamimab is under investigation in clinical trial NCT02312206 (The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis).

  10. Drug

    ENTR-601-44

    go.drugbank.com/drugs/DB17836
    Investigational

    ENTR-601-44 is an exon 44 skipping phosphorodiamidate morpholino oligonucleotide (PMO). Developed by Entrada Therapeutics, it was investigated for the treatment of Duchenne muscular dystrophy.[L46641]